Navigation Links
Physicians Anticipate Changes in Their Usage of Hip Implants
Date:4/21/2008

Millennium Research Group survey finds that approximately 45% of physicians intend to increase their usage of ceramic hip implants over the next two

years

WALTHAM, Mass., April 21 /PRNewswire/ -- According to a recent study conducted by Millennium Research Group (MRG) at the American Academy of Orthopedic Surgeons' annual meeting in San Francisco, CA, physicians anticipate changes in their usage of different acetabular bearing surfaces over the next 24 months.

Physician feedback indicated that over the next two years, 45% of respondents expect to increase their use of ceramic acetabular components in reconstructive hip implant surgery. Similarly, nearly 30% of respondents also indicated they would increase their use of metal acetabular bearing surfaces. Concerns related to the release of particulate debris from traditional polyethylene bearings, which leads to implant loosening and joint infections, has created increased interest in alternative bearing surfaces that are constructed from highly cross-linked polyethylene (HXLPE), metal, ceramic, or hybrid materials.

"Surgeons indicated that clinical results and patient needs had the highest impact on their choice of bearing surface," says Andrea Cheng, Senior Analyst at Millennium Research Group. "As a result, over 50% of physicians surveyed used more than one type of acetabular bearing surface to reflect the diverse needs of their patients."

The results of this survey, as well as detailed market analyses, are included in Millennium Research Group's US Markets for Large Joint Reconstructive Implants 2008 report which includes industry competitors such as Biomet, DePuy, Exactech, Smith & Nephew, Stryker, Wright Medical Technology, and Zimmer.

About Hip Implants

Primary total hip arthroplasty (THA) procedures are performed to replace the complete hip joint. Primary THA devices consist of three components: a femoral stem, a femoral head, and an acetabular cup. The stem is commonly made from either cobalt or titanium alloys and is inserted into the reamed femur and affixed into place. The acetabular cup forms the replacement socket of the joint and is traditionally made from metal alloys with a polyethylene inner lining.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports, surveys, focus groups, and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Physician Hospitals of America Denounces Farm Bill Plan to Sell Out Seniors and Physicians to Pay for Agribusiness Subsidies
2. Physicians: McCains Health Care Plan More Realistic Than Obamas and Clintons
3. Patient charter ensures that reports on physicians are meaningful, reliable and fair
4. Patient charter ensures that reports on physicians are meaningful, reliable, and fair
5. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
6. Indiana University study finds majority of US physicians favor national health insurance
7. Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline
8. Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care
9. Morgan Fairchild Joins Neurologists, Emergency Physicians and the American Stroke Association to Educate the Public About Stroke Symptoms
10. TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians
11. HHS Secretary Leavitt Praised for Defending Physicians Conscience Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: